Completed PHASE4 INTERVENTIONAL 2-arm NCT01871753

The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria (BiRT)

The Bacteriuria in Renal Transplantation (BiRT) Study: A Prospective, Randomized, Parallel-group, Multicenter, Open-label, Superiority Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria

Sponsor: Centre Hospitalier Epicura, Belgium

Conditions Asymptomatic Bacteriuria Bacteriuria Kidney Transplantation Urinary Tract Infections

Interventions Anti-Infective Agents

Updated 9 times since 2017 Last updated: Jul 16, 2019 Started: Apr 30, 2014 Primary completion: Jul 31, 2019 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01871753, this PHASE4 trial focuses on Asymptomatic Bacteriuria and Bacteriuria and remains completed. Sponsored by Centre Hospitalier Epicura, Belgium, it has been updated 9 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Aug 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 4 earlier versions

Jun 2019 — Aug 2019 [monthly]

Recruiting PHASE4
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE4
Feb 2018 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Epicura, Belgium
Centre Hospitalier Universitaire Brugmann
Centre Hospitalier Universitaire de Charleroi
Erasme University Hospital
Hôpital Necker Enfants-Malades, Université de Paris Descartes, APHP, France
Nantes University Hospital
Universitair Ziekenhuis Brussel
University Ghent
University Hospital, Lille
University of Liege

Data source: Erasme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Antwerp, Belgium , Baudour, Belgium , Brussels, Belgium , Charleroi, Belgium , Créteil, France , Ghent, Belgium , Lille, France , Liège, Belgium , Nantes, France , Paris, France and 2 more locations